C R Antonescu
Overview
Explore the profile of C R Antonescu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
2556
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bansal R, Antonescu C, Thibodeau R, Tulla K
Acta Gastroenterol Belg
. 2022 Jun;
85(2):416-417.
PMID: 35709793
No abstract available.
2.
Stacchiotti S, Miah A, Frezza A, Messiou C, Morosi C, Caraceni A, et al.
ESMO Open
. 2021 Jun;
6(3):100170.
PMID: 34090171
Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is...
3.
Demetri G, Antonescu C, Bjerkehagen B, Bovee J, Boye K, Chacon M, et al.
Ann Oncol
. 2020 Sep;
31(11):1506-1517.
PMID: 32891793
Sarcomas are a heterogeneous group of malignancies with mesenchymal lineage differentiation. The discovery of neurotrophic tyrosine receptor kinase (NTRK) gene fusions as tissue-agnostic oncogenic drivers has led to new personalized...
4.
Ho A, Dunn L, Sherman E, Fury M, Baxi S, Chandramohan R, et al.
Ann Oncol
. 2016 Aug;
27(10):1902-8.
PMID: 27566443
Background: Recurrent/metastatic adenoid cystic carcinoma (ACC) is an incurable disease with no standard treatments. The majority of ACCs express the oncogenic transcription factor MYB (also c-myb), often in the context...
5.
DAngelo S, Antonescu C, Kuk D, Qin L, Moraco N, Carvajal R, et al.
Br J Cancer
. 2013 Oct;
109(9):2340-6.
PMID: 24104962
Background: Radiation-associated breast angiosarcoma (RT-AS) is an uncommon malignancy with an incidence of less than 1 % of all soft tissue sarcomas. The overall prognosis is quite dismal with high...
6.
Dickson M, Okuno S, Keohan M, Maki R, DAdamo D, Akhurst T, et al.
Ann Oncol
. 2012 Aug;
24(1):252-7.
PMID: 22898035
Background: HSP90 inhibition leads to proteosomal degradation of activated KIT and has in vitro activity against gastrointestinal stromal tumors (GIST). BIIB021 is an oral non-ansamycin HSP90 inhibitor. We carried out...
7.
Italiano A, Toulmonde M, Cioffi A, Penel N, Isambert N, Bompas E, et al.
Ann Oncol
. 2011 Nov;
23(6):1601-7.
PMID: 22039081
Background: Data regarding the role of systemic therapy in patients with advanced well-differentiated/dedifferentiated liposarcomas (WDLPS/DDLPS) are limited. Methods: From 2000 to 2010, 208 patients with advanced WDLPS/DDLPS received chemotherapy in...
8.
McCarter M, Lewis J, Antonescu C, Brennan M
Sarcoma
. 2008 Jun;
4(3):119-23.
PMID: 18521290
Purpose. Extraskeletal osteosarcoma represents an unusual soft-tissue sarcoma that historically is reported to carry an exceptionally poor prognosis.The objectives of this study were to use a prospectively gathered sarcoma database...
9.
Antonescu C
Histopathology
. 2005 Dec;
48(1):13-21.
PMID: 16359533
Soft tissue tumours represent a heterogeneous group of mesenchymal lesions and their classification continues to evolve as a result of incorporating advances in cytogenetic and molecular techniques. In the last...
10.
Antonescu C, Huvos A
Am J Clin Pathol
. 2002 May;
114 Suppl:S90-103.
PMID: 11996175
Osteosarcomas represent a heterogeneous group of tumors with different histologic and clinical features, biologic behavior, and therapy. Histologic grading has remained the most important factor for predicting the clinical progression...